Mediators of Inflammation

Control and Resolution Mechanisms of the Inflammatory Response 2016


Publishing date
05 Aug 2016
Status
Published
Submission deadline
18 Mar 2016

1Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico

2Universidad Nacional Autónoma de México, Mexico City, Mexico

3Instituto Mexicano del Seguro, Ciudad de México, Mexico

4Universidad de Buenos Aires, Buenos Aires, Argentina


Control and Resolution Mechanisms of the Inflammatory Response 2016

Description

The inflammatory response is a fundamental physiologic process to protect cells from infection and other noxious stimuli. Inflammation is terminated by endogenous anti-inflammatory and proresolving mediators to restore homeostasis; however, failing in the control and resolution of inflammation may lead to chronic inflammation which is characteristic in many chronic-degenerative diseases, that is, cancer, diabetes, and autoimmune and cardiovascular diseases, with devastating consequences for human health. Development of tools and strategies to control the chronic inflammatory response needs to be based on a profound knowledge of its subjacent cellular and molecular mechanisms. Having this in mind, we cordially invite authors to submit original and review articles that contribute to understanding of the natural and exogenously induced process that controls and resolves inflammation and helps to establish new routes between the complex inflammatory reactions and the strategies to regulate them.

Potential topics include, but are not limited to:

  • Signalling pathways that contribute to the control or resolution of inflammation (i.e., TLR, TGF-β, etc.)
  • Resolvins as drug candidates for inflammatory diseases
  • Control or resolution of chronic inflammation in obesity and metabolic syndrome
  • Contribution of proresolving mediators in the prevention of chronic degenerative diseases (i.e., cancer, diabetes, and autoimmune and cardiovascular diseases)
  • Nervous system role in the control or resolution of inflammation (i.e., inflammatory reflex)
  • Control or resolution mechanisms induced by natural or synthetic compounds
  • Control or resolution mechanisms induced by immune cells

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 3634948
  • - Review Article

Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders

A. Janus | E. Szahidewicz-Krupska | ... | A. Doroszko
  • Special Issue
  • - Volume 2016
  • - Article ID 7465852
  • - Review Article

Role of Porphyromonas gingivalis HmuY in Immunopathogenesis of Chronic Periodontitis

P. C. Carvalho-Filho | I. S. Gomes-Filho | ... | S. C. Trindade
  • Special Issue
  • - Volume 2016
  • - Article ID 7174127
  • - Research Article

Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice

Georg D. Duerr | Daniela Dewald | ... | Oliver Dewald
  • Special Issue
  • - Volume 2016
  • - Article ID 8243601
  • - Clinical Study

Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid

Marco Bigoni | Marco Turati | ... | Antonio Torsello
  • Special Issue
  • - Volume 2016
  • - Article ID 6978936
  • - Review Article

The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation

Monica Molteni | Sabrina Gemma | Carlo Rossetti
  • Special Issue
  • - Volume 2016
  • - Article ID 8727289
  • - Research Article

Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells

Giusy Daniela Albano | Anna Bonanno | ... | Mirella Profita
Mediators of Inflammation
 Journal metrics
Acceptance rate36%
Submission to final decision53 days
Acceptance to publication29 days
CiteScore6.000
Impact Factor3.758
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.